1
|
Schmid-Grendelmeier P, Takaoka R, Ahogo KC, Belachew WA, Brown SJ, Correia JC, Correia M, Degboe B, Dorizy-Vuong V, Faye O, Fuller LC, Grando K, Hsu C, Kayitenkore K, Lunjani N, Ly F, Mahamadou G, Manuel RCF, Kebe Dia M, Masenga EJ, Muteba Baseke C, Ouedraogo AN, Rapelanoro Rabenja F, Su J, Teclessou JN, Todd G, Taïeb A. Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap. J Eur Acad Dermatol Venereol 2020; 33:2019-2028. [PMID: 31713914 PMCID: PMC6899619 DOI: 10.1111/jdv.15972] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Accepted: 09/05/2019] [Indexed: 02/06/2023]
Abstract
BACKGROUND The first International Society of Atopic Dermatitis (ISAD) global meeting dedicated to atopic dermatitis (AD) in Sub-Saharan Africa (SSA) was held in Geneva, Switzerland in April 2019. A total of 30 participants were present at the meeting, including those from 17 SSA countries, representatives of the World Health Organization (WHO), the International Foundation for Dermatology (IFD) (a committee of the International League of Dermatological Societies, ILDS www.ilds.org), the Fondation pour la Dermatite Atopique, as well as specialists in telemedicine, artificial intelligence and therapeutic patient education (TPE). RESULTS AD is one of the most prevalent chronic inflammatory skin diseases in SSA. Besides neglected tropical diseases (NTDs) with a dermatological presentation, AD requires closer attention from the WHO and national Departments of Health. CONCLUSIONS A roadmap has been defined with top priorities such as access to essential medicines and devices for AD care, in particular emollients, better education of primary healthcare workers for adequate triage (e.g. better educational materials for skin diseases in pigmented skin generally and AD in particular, especially targeted to Africa), involvement of traditional healers and to a certain extent also patient education, bearing in mind the barriers to effective healthcare faced in SSA countries such as travel distances to health facilities, limited resources and the lack of dermatological expertise. In addition, several initiatives concerning AD research in SSA were discussed and should be implemented in close collaboration with the WHO and assessed at follow-up meetings, in particular, at the next ISAD meeting in Seoul, South Korea and African Society of Dermatology and Venereology (ASDV) meeting in Nairobi, Kenya, both in 2020.
Collapse
Affiliation(s)
| | - R Takaoka
- Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil
| | - K C Ahogo
- Département de médecine et Spécialités Médicales, Dermatologie et Vénérologie, CHU Treichville, Université Félix Houphouët-Boigny UFR Sciences Médicales, Abidjan, Côte d'Ivoire
| | - W A Belachew
- College of Health Science, Ayder Comprehensive Specialized Teaching Hospital, Mekelle University, Mekelle, Ethiopia
| | - S J Brown
- Skin Research Group, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK
| | - J C Correia
- Division of Therapeutic Education for Chronic Diseases, WHO Collaborating Center, Department of First Aid Medecine, Geneva University Hospitals, Geneva, Switzerland
| | - M Correia
- Department of Dermatology, Hospital Cuf Descobertas and Hospital Cuf Torres Vedras, Torres Vedras, Portugal
| | - B Degboe
- Department of Dermatology, Faculty of Health Sciences, National and Teaching Hospital HKM of Cotonou, University of Abomey-Calavi, Cotonou, Benin
| | - V Dorizy-Vuong
- Department of Adult and Pediatric Dermatology, CHU Bordeaux, Bordeaux, France.,INSERM U 1035, University of Bordeaux, Bordeaux, France
| | - O Faye
- Department of Dermatology, Faculty of Medicine, CNAM, Bamako, Mali
| | - L C Fuller
- Chair of International Foundation for Dermatology, Chelsea and Westminster Hospital, London, UK
| | - K Grando
- Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
| | - C Hsu
- Department of Dermatology, Teledermatology and AI, University Hospital of Basel, Basel, Switzerland
| | - K Kayitenkore
- Kigali Dermatology Center, University of Rwanda, Kigali, Rwanda
| | - N Lunjani
- University of Cape Town, Cape Town, South Africa
| | - F Ly
- Université Cheikh Anta Diop, Dakar, Senegal
| | - G Mahamadou
- Department of Adult and Pediatric Dermatology, CHU Bordeaux, Bordeaux, France.,Service de Dermatologie-Vénéréologie, CHU Sylvanus Olympio, Lomé, Togo
| | - R C F Manuel
- Department of Dermatology, Ministry of Health, Hospital Central de Maputo, Maputo, Mozambique
| | | | - E J Masenga
- Regional Dermatology Training Center, Kilimanjaro Christian Medical University College, Moshi, Tanzania
| | - C Muteba Baseke
- Clinique Bondeko, Kinshasa-Limete, Democratic Republic of the Congo
| | - A N Ouedraogo
- University Hospital Yalgado Ouedraogo of Ouagadougou, University Ouaga I Pr Joseph Ki-Zerbo Ouagadougou, Ouagadougou, Burkina Faso
| | - F Rapelanoro Rabenja
- Department of Dermatology, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar
| | - J Su
- Department of Paediatrics, Murdoch Children's Research Institute, Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia
| | - J N Teclessou
- Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Lomé, Togo
| | - G Todd
- Department of Medicine, University of Cape Town, Cape Town, South Africa
| | - A Taïeb
- Department of Adult and Pediatric Dermatology, CHU Bordeaux, Bordeaux, France.,INSERM U 1035, University of Bordeaux, Bordeaux, France
| |
Collapse
|